SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Antigen‐antibody combination assays for blood donor screening: weighing the advantages and costs
2 references·4 citing·24 second hop
Antigen‐antibody combination assays for blood donor screening: weighing the advantages and costs (2008)Antigen‐antibody combination assays for b…Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Cost‐effectiveness of nucleic…HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation (2003)HIV antibody screening remain…Overview of Blood Mixers for Transfusion Therapy: Characteristics, Features, and Development Potential (2020)Overview of Blood Mixers for …Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil (2015)Does offering human immunodef…Quarantine Plasma: Quo vadis? (2010)Quarantine Plasma: Quo vadis?Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: implications for sequential immunoassay testing algorithms in other countries (2010)Performance of parallel scree…Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays (2003)Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS‐II study, 2007 to 2008 (2009)The Risk of Transfusion-Transmitted Viral Infections (1996)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya (2011)Molecular virology in transfusion medicine laboratory. (2013)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)First report of human immunodeficiency virus transmission via an RNA‐screened blood donation (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A novel approach to detect test‐seeking behaviour in the blood donor population: making the invisible visible (2016)Methods for the economic evaluation of health care programmes (1987)Perception of Risk (1987)Cost-Effectiveness in Health and Medicine (1996)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Cost-Effectiveness Analysis: What It Really Means for Transfusion Medicine Decision Making (2008)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Safeguards in Blood Supply: A National and European Challenge (2010)Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men (2023)Donation reactions among autologous donors (1990)Импортозависимость и импортозамещение в российской обрабатывающей промышленности: взгляд бизнеса (2016)The global need and availability of blood products: a modelling study (2019)
this work references cited by second hop

References

  • 2004Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States136 cited
  • 2003HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation25 cited

Cited by

  • 2010Quarantine Plasma: Quo vadis?17 cited
  • 2010Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: implications for sequential immunoassay testing algorithms in other countries9 cited
  • 2020Overview of Blood Mixers for Transfusion Therapy: Characteristics, Features, and Development Potential8 cited
  • 2015Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work